Empresa Sienna Biopharmaceuticals, Inc. Other OTC
Acciones
SNNAQ
US82622H1086
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Founder | 59 | 27/06/10 | |
Majed Kheir
COO | Chief Operating Officer | 46 | 01/01/16 |
Silvio Traversa
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/12/16 |
Sean P. Andrews
IRC | Investor Relations Contact | - | - |
General Counsel | 45 | 01/10/16 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Dennis Fenton
BRD | Director/Board Member | 72 | 01/10/16 |
Founder | 59 | 27/06/10 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 31 050 542 | 30 907 542 ( 99,54 %) | 143 000 ( 0,4605 %) | 99,54 % |
Información de la empresa
Sienna Biopharmaceuticals, Inc.
30699 Russell Ranch Road Suite 140
91362, Westlake Village
+
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+8,96 % | 105 mil M | |
-1,43 % | 104 mil M | |
+4,40 % | 22,94 mil M | |
-12,15 % | 22,34 mil M | |
-4,36 % | 19,25 mil M | |
-39,98 % | 17,08 mil M | |
-10,04 % | 16,96 mil M | |
+6,79 % | 14,16 mil M | |
+38,61 % | 12,63 mil M |